Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

about

Are acute coronary syndromes an ideal scenario for bioresorbable vascular scaffold implantation?

Item

http://www.wikidata.org/entity/Q47686997

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Are acute coronary syndromes a ...... ascular scaffold implantation?

@en

Are acute coronary syndromes a ...... ascular scaffold implantation?

@nl

type

Item

label

Are acute coronary syndromes a ...... ascular scaffold implantation?

@en

Are acute coronary syndromes a ...... ascular scaffold implantation?

@nl

prefLabel

Are acute coronary syndromes a ...... ascular scaffold implantation?

@en

Are acute coronary syndromes a ...... ascular scaffold implantation?

@nl

P1476

Are acute coronary syndromes a ...... ascular scaffold implantation?

@en

P2093

Alfonso Ielasi

http://www.w3.org/2001/XMLSchema#string

Attilio Varricchio

http://www.w3.org/2001/XMLSchema#string

Elisabetta Moscarella

http://www.w3.org/2001/XMLSchema#string

Enrico Cerrato

http://www.w3.org/2001/XMLSchema#string

Fortunato Scotto di Uccio

http://www.w3.org/2001/XMLSchema#string

Gianluca Campo

http://www.w3.org/2001/XMLSchema#string

Maria Carmen De Angelis

http://www.w3.org/2001/XMLSchema#string

Roberta De Rosa

http://www.w3.org/2001/XMLSchema#string

P2860

Acute coronary syndromes: diagnosis and management, part I

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry.

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.

Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial.

A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study.

Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

P304

S969-S978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.06.136

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28894603

http://www.w3.org/2001/XMLSchema#string

P932

5583090

http://www.w3.org/2001/XMLSchema#string